You are here

  • Home
  • Archive
  • Volume 10, Issue 4
  • Eye movement desensitisation and reprocessing reduces PTSD symptoms compared with fluoxetine at six months post-treatment

Article Text

Article menu
Download PDFPDF
Therapeutics
Eye movement desensitisation and reprocessing reduces PTSD symptoms compared with fluoxetine at six months post-treatment

http://dx.doi.org/10.1136/ebmh.10.4.118

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Is eye movement desensitisation and reprocessing more effective than fluoxetine in people with post-traumatic stress disorder?

    van der Kolk BA, Spinazzola J, Blaustein ME, et al. A randomized clinical trial of eye movement desensitization and reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance. J Clin Psychiatry 2007;68:37–46.

    METHODS

    Embedded ImageDesign:

    Randomised controlled trial.

    Embedded ImageAllocation:

    Concealed.

    Embedded ImageBlinding:

    Double blind.

    Embedded ImageFollow-up period:

    Eight months (2 months’ treatment plus 6 months’ post-treatment follow-up).

    Embedded ImageSetting:

    Recruitment via newspaper ads, the Internet, and from medical and mental health professionals, USA; July 2000 to July 2003.

    Embedded ImagePatients:

    88 people aged 18–65 years old with current post-traumatic stress disorder (PTSD) (DSM-IV) and mixed trauma exposure at least one year before enrolment. Main exclusions: contraindication to study treatments, previous use of study treatments, Global assessment of functioning score <40, unstable medical comorbidity, psychotic or bipolar disorder, alcohol or …

    View Full Text

    Footnotes

    • Source of funding: National Institute of Mental Health, USA.

    Footnotes

    • Competing interests: None.